Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses. (Q41630631)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 October 2014

Language	Label	Description	Also known as
English	Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses.	scientific article published on 30 October 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

based on heuristic

inferred from title

Salmonella typhi

object named as

Salmonella typhi

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Miriam Lastre

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Laura Reyes

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Elizabeth González

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yusnaby Borrero

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Diandra Lescaille

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Rocmira Pérez

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Darzy Nuñez

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Oliver Pérez

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

0 references

publication date

30 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

6971-6978

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Key roles of adjuvants in modern vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

New vaccines require potent adjuvants like AFPL1 and AFCo1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Can successful vaccines teach us how to induce efficient protective immune responses?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Development of Vi conjugate - a new generation of typhoid vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

The advantage of mucosal immunization for polysaccharide-specific memory responses in early life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Pneumococcal polysaccharide abrogates conjugate-induced germinal center reaction and depletes antibody secreting cell pool, causing hyporesponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Role of capsular polysaccharide in Group B Streptococccus interactions with dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Targeting immune response induction with cochleate and liposome-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

What is and what should always have been: long-lived plasma cells induced by T cell-independent antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

T cell-independent B cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Toll-like receptor agonists allow generation of long-lasting antipneumococcal humoral immunity in response to a plain polysaccharidic vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Mucosal clearance of capsule-expressing bacteria requires both TLR and nucleotide-binding oligomerization domain 1 signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41630631&oldid=1799636984"